Dec 2, 2025BoardMeeting
BoardInstitutional Biosafety Committee Meeting Minutes
The committee reviewed and acted upon several research applications involving recombinant nucleic acid. They unanimously approved the application from Dr. Mercer pending specified document revisions and containment adjustments. The application from Dr. Sanchez regarding Orientia tsutsugamushi was tabled pending further institutional and regulatory support for utilizing a Risk Group 3 organism. Additionally, a second application from Dr. Sanchez concerning Rickettsia montanensis was approved pending clarifications regarding experimental methodology and pathogen virulence assessments.